×
0 0 0 0.0387596899224806 0.0077519379844961 -0.0248062015503876 -0.0255813953488372 -0.0248062015503876
Stockreport

BRIEF-Immunomedics reports preclinical study presented at 2017 AACR annual meeting [Reuters]

IMMUNOMEDICS (IMMU)  More Company Research Source: Reuters
Last immunomedics earnings: 2/8 04:15 pm Check Earnings Report
PDF BRIEF-Immunomedics reports preclinical study presented at 2017 AACR annual meeting April 4 Immunomedics Inc: * Immunomedics reports immu-132 delivers high levels ofsn-38 that overcome chemoresistant tumors with moderate tostrong trop-2 expressionSource text for Eikon:Further company coverage: [Read more]

IMPACT SNAPSHOT EVENT TIME: IMMU
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS